Hematology/Oncology Residency Audie L. Murphy Memorial VA Hospital
PharmD University of Texas at Austin
BS University of Utah
Associate Professor, Department of Pharmacy Practice & Science
Director, Hematology / Oncology Pharmacy Practice Residency
Dr. Val Adams
Dr. Adams is on the graduate faculty of the College of Pharmacy and is a member of the Lucille Parker Markey Cancer Center, where he has a clinical practice site. As director of the hematology/oncology residency program, he has trained four residents and maintains an active research lab. Dr. Adams received his bachelor of science degree in pharmacy from the University of Utah and doctor of pharmacy degree from the University of Texas at Austin jointly with the University of Texas Health Science Center at San Antonio. He completed a residency in hematology/oncology at the Audie L. Murphy Memorial V.A. Hospital in San Antonio, Texas. He then completed a two-year fellowship in immunology and transplantation at the University of Florida. Following the completion of the fellowship, he joined the University of Kentucky faculty in 1996. Research interests: topoisomerase I inhibitors and topoisomerase expression, chemotherapy-induced toxicity, and supportive care issues, including pain control and nutritional effects on chemotherapy outcomes.
Flannery Alexander H, Adams Val R, Burgess David. (2014). Optimizing Postgraduate Year 3 Training.American Journal of Health-System Pharmacy, 71(22), 1924-5.
Adams Val R, Balko J. (2013). Lung Cancer.McGraw-Hill, Chapter 90.
DeFrates S R, McDonagh Kevin Thomas, Adams Val R. (2013). The Reversal of Inhibitors in Congenital Hemophilia.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy/Wiley, 33(2), 157-64.
Medina P J, Adams Val R. (2013). Cancers and Tumor Markers .American Society of Health-System Pharmacists, Chapter 19.
Piascik Mary M, Adams Val R. (2013). Dispensing Biotechnology Products:Handling, Professional Education and Product Information.Chapter 9.
Adams Val R, DeRemer David L, Holdsworth Mark T. (2013). Guide to Cancer Therapeutic Regimens. . McMahon Publishing,